Physician profile
Emily Love
NPI 1215319165
$34,635.08
in general payments reported to CMS, 2019-2025
24 companies · $28.06 in 2025
The $28.06 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,969 · 2020: $346 · 2021: $625 · 2022: $2,497 · 2023: $16K · 2024: $13K · 2025: $28.06.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $22K · Food and Beverage: $3,426 · Travel and Lodging: $3,362 · Entertainment: $115 · Education: $35.68.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $22,260.00 |
| Food and Beverage | $3,425.61 |
| Travel and Lodging | $3,361.95 |
| Entertainment | $114.67 |
| Education | $35.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dompe US, INC. | $28,773.01 | 2019-2024 | Oxervate |
| Shire North American Group INC | $1,070.90 | 2019 | |
| Glaukos Corporation | $709.78 | 2019-2024 | Istent Trabecular Micro-Bypass System Model Is3, Kxl System (Not Refurbished), Ce-Marked Kxla System |
| Allergan, INC. | $565.46 | 2019-2022 | |
| Sun Pharmaceutical Industries INC. | $452.59 | 2019-2024 | Cequa |
| Bausch & Lomb Americas INC. | $451.03 | 2022-2024 | Miebo, Xiidra, Infuse |
| Novartis Pharmaceuticals Corporation | $427.37 | 2019-2023 | |
| Alcon Vision LLC | $407.80 | 2022-2024 | Rocklatan |
| Oyster Point Pharma, INC. | $341.64 | 2022-2024 | Tyrvaya, Ryzumvi |
| Abbvie INC. | $265.67 | 2022-2025 | |
| Sight Sciences, INC. | $212.02 | 2019-2024 | Omni Surgical System |
| Kala Pharmaceuticals, INC. | $171.66 | 2019-2022 | |
| Johnson & Johnson Vision Care, INC. | $164.94 | 2019-2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $164.54 | 2019-2021 | |
| Optos, INC. | $114.67 | 2024 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $102.14 | 2023 | Misight Contact Lens |
| Horizon Therapeutics Plc | $65.90 | 2023 | Tepezza |
| Amgen INC. | $57.25 | 2024 | Tepezza |
| Biotissue Holdings INC. | $46.05 | 2023 | |
| Ani Pharmaceuticals, INC. | $19.89 | 2024 | Purified Cortrophin Gel |
| Johnson & Johnson Surgical Vision, INC. | $17.41 | 2019 | |
| Harrow Eye, LLC | $15.82 | 2024 | Vevye |
| Aerie Pharmaceuticals, INC. | $12.15 | 2020 | |
| Maculogix, INC. | $5.39 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Love listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.